Loading

Journal of Neurological Disorders and Stroke

Early Risk and Influence Factors on Death of Sepsis Following Acute Intracerebral Hemorrhage: A Retrospective Cohort Study

Research Article | Open Access | Volume 7 | Issue 1

  • 1. Department of Neurology, Xuzhou Medical University, China
  • 2. Department of Surgery, Xuzhou Medical University, China
  • 3. Department of Intensive Care Medicine, Xuzhou Medical University, China
+ Show More - Show Less
Corresponding Authors
Tong DM, Department of Neurology, Affiliated Shuyang Hospital, Xuzhou Medical University, No. 9, Yingbin Road, Shu town, Jiangsu 223600, China
ABSTRACT

Background: The early risk and influence factors on death of sepsis following acute intracerebral hemorrhage (ICH) was previously unclear.

Methods: We retrospectively enrolled patients with identified sepsis after acute ICH from an ICU in China. We used Systemic Inflammatory Response Syndrome (SIRS) criteria to screen infection, and used Sequential Organ Failure Assessment (SOFA) criteria to diagnosis sepsis after acute ICH. The odd ratios (OR) of risk and outcome for sepsis were estimated by logistic regression.

Results: Among 507 acute ICH patients, 189 (37.3%, 189/507) had sepsis events during their hospitalizations. The early risk of sepsis in ICH patients at initial 48 hours was in 21.9% (111/507). The mortality of sepsis at initial 48 hours was in 49.5%. The main factor of influence early death was related to no using antibiotics within initial 3 hours (OR, 0.3; 95% CI, 0.153- 0.506), higher SOFA score (OR, 1.5; 95% CI, 0.304- 0.673), and higher SIRS criteria (OR, 1.5; 95% CI, 1.209- 1.938). At 30 days, the mortality of sepsis after ICH was in 55.6%, and the influence on death was associated with elevated serum lactate levels (OR, 1.3; 95% CI, 1.190-1.402), elevated SOFA scores (OR, 1.1; 95% CI, 1.032-1.151), higher NIHSS scores (OR, 1.1; 95% CI, 1.074-1.141), less ICU days (OR, 0.8; 95% CI, 0.734-845), and decreased GCS scores (OR, 0.7; 95% CI, 0.641-0.834).

Conclusions: High risk sepsis is an early complication and with high mortality following acute ICH. The antibiotics treatment for sepsis after ICH must be performed early.

CITATION

Tong DM, Zhou YT, Wang SD, Wang GS, Wang YW, et al. (2020) Early Risk and Influence Factors on Death of Sepsis Following Acute Intracerebral Hemorrhage: A Retrospective Cohort Study. J Neurol Disord Stroke 7(1): 1152.

KEYWORDS

• Sepsis
• Infection
• Acute organ dysfunction
• Acute intracerebral hemorrhage
• Incidence
• Mortality

INTRODUCTION

The acute spontaneous intracerebral hemorrhage (ICH) is the most common causes (26.0%) of critical illness in the intensive care unit (ICU) [1], with a 30-day mortality rate is 43%-52% [2,3]. Moreover, nearly half of these deaths occur during the first 2 days [3]. Transient survivors might still suffer from a lifethreatening event due to not only neurological complications (e.g., brain edema, cerebral ischemia, and seizures) but also nonneurological complications, including pneumonia, respiratory failure/distress, and sepsis [4,5]. Recently, the incidence of highrisk systemic infections in ICH patients occur about 31% to 58% [6,7]. Moreover, sepsis is defined as a life-threatening organ dysfunction due to a dysregulated host response to infection [8]. However, few availability report was found the trends of risk and influence on outcome for sepsis following patients with acute ICH. Our hypothesis was that the highest risk of sepsis after acute ICH would is within anitial 48 hours and with high mortality. The aim of this study was to assess whether sepsis after acute ICH would be with an early high risk and increased mortality. This study could facilitate early identification and more timely using antibiotics treatment for ICH patients with sepsis.

METHODS

Study settings

This study was a retrospective study of one -centers registered patients who were in the ICU of the Affiliated Shuyang Hospital of Xuzhou Medical University in Northern China (January 1, 2013 through December 31, 2017). This hospitals are the national hospital of three teaching levels. The study was approved by the ethical committee on clinical research of the Affiliated Shuyang Hospital of Xuzhou Medical University. Because the study involved only a review of records obtained as a part of routine medical care, did not require all patients to write the information consent.

Identification of patients

Using the guidelines for the diagnosis of spontaneous intracerebral hemorrhage from the American Heart Association/American Stroke Association (2015) [9]. We identified patients who had acute spontaneous ICH within the study period based on the prospective registration of their primary diagnosis in the ICU. We also examined the electronic medical records of these patients who were verified as having an acute ICH according to their cranial CT scan in emergency or in the first 24 hours after admission. Patients with a subdural hematoma, secondary ICH resulting from an underlying neoplasm, ICH resulting from an annticoagulation, and ICH due to the hemorrhagic transformation of an ischemic infarct were not included. We excluded the ICH patients who did not have data in their medical records due to either death/moribundity within first 24 hours.

Inclusion criteria for sepsis after acute ICH

Based on the new definition of sepsis-3, sepsis is one/more acute life-threatening organ dysfunction caused by infection. In this study, most patients had a primary brain failure due to acute ICH at initial. Thus, the inclusion criteria for sepsis after acute ICH had to include the following criteria: (1) a total of sequential [sepsis- related] organ failure assessment (SOFA) score >4; or a SOFA score for brain ≥2; (2) a systemic inflammatory response syndrome (SIRS) criteria ≥ 2; or with confirmed infection. We excluded those patients who were presented with evidence of organ dysfunction due to the effects of sedatives/other medications or non-infection related organ failure.

Identification of infection events and organ failure events

We identified infection events using a SIRS criteria ≥ 2 within initial 24 hours on the ICUs, which were used to screen infection events by previous studies (≥ 2 criteria for positive) [10-12]. The SIRS criteria as follows: (1) temperature greater than 38 or less than 36; (2) heart rate greater than 90 beats per minute;(3) tachypnea >20 respirations per minute or Pco2 <32mmHg; (4) white blood cell count greater than 12.0×109 /L or less than 4.0×109 /L, or more than 10% band forms. We also used quick CT scans to confirm a thorax infection.

The SOFA scores were calculated for one or more organ dysfunction after acute ICH, which was measured within 24 hours, 48 hours, and 72 hours or more later on the ICU admission. The acute organ dysfunction was defined as equivalent to a SOFA score ≥ 2 for a particular organ (on a scale from 0 to 4, with higher scores indicating multi-organ failure) [13].

The SOFA criteria used to assess acute brain failure as follow: the GCS score=10-12 points were only a mild brain failure (SOFA=2), and GCS 4 for brain; or a SOFA score ≥2 with brain imaging not be explained by factors other than a septic brain failure. The SOFA criteria for other organ failure are shown in The Supplement Table 1.

Clinical assessments

All patients underwent an initial brain CT scan on admission and at least one repeat brain CT scan after coma onset. We analyzed the CT data that were collected at the closest in time following onset. The hematoma volumes on admission were measured using the standard ABC/2 formula (A is the longest diameter of the hematoma, B is the widest diameter of the hematoma, and C is the thickness of the hematoma) [14].

The hospital charts of all ICH patients with and without sepsis were reviewed by a senior author (TDM) to extract the detailed clinical information about infections, organ dysfunction, and other findings during the study period. To assess the relationship between in-ICU mortality of sepsis patients at 48 hours and antbiotics treatment in initial 3 hours, we focused on the time from admission to starti antibiotic treatment.

Significant intracerebral hemorrhage growth was defined by a hematoma expansion of greater than one-third on a repeat CT scan [15], or hematoma enlargement leading to a brain herniation. Brain herniation was divided into uncal and central types [16].

Patients outcomes

The neurological status at 30 days was assessed using the Glasgow Outcome Scale (GOS; ranging from 1=death to 5=good recovery) obtained from the medical records. If the patient was moribundity transferred out of ICU, the information was from the interviewed proxies to ascertain the circumstances of the participant’s death.

Statistical methods

Discrete data are presented as numbers and percentages, means and standard deviations, medians and interquartile ranges, or proportions with 95% confidence intervals. Accordingly, chi-square tests were summarized as numbers with percentages. Independent t test were used to compare differences in continuous variables between the two groups. Chisquared tests were used to explore the relationships between baseline variables. Multivariate-adjusted odd ratios (ORs) and 95% confidence intervals (CIs) were estimated using a logistic regression model. The Cox proportional hazards model was used to examine baseline sepsis status and to determine whether the variables played a role in the risk of death during the first 30days. Survival analysis was performed using the Kaplan-Meier curve method. Differences between groups were considered significant if the p-values were <0.05.The statistical calculations were performed using a commercial computerized statistics package (SPSS 10.0).

Table 1: Characteristics of sepsis after acute ICH patients, N=189.

Characteristics All cases (N=189)
Female, n (%) 75 (39.7)
Median age (years, range) 62.7(30-94)
Median time from onset to infection (h, range) 1.3 (0,5-120.0)
Site of infection  
Respiratory n (%) 140 (74.1)
Urinary tract, n (%) 23 (12.2)
Intestinal tract, n (%) 11(5.8)
Other, n (%) 15 (7.9)
Possitive body fluid culture, n (%) 90 (48.9) §
Sepsis-related organ failure  
Brain failure, n (%) 141(74.6)?
Septic shock, n (%) 23 (12.2)
Respiratory failure, n (%) 56 (29.6)
Renal failure, n (%) 31 (16.4)
Hepatic failure, n (%) 16 (8.5)
Multiple organ failure, n (%) 63 (33.3)
Mortality of sepsis at initial 48 hrs, n (%) 55 (49.5)
Mortality of sepsis at 30 days, n (%) 105 (55.6)
§, including blood culture, sputun culture, and urine culture., brain failure due to a nosocomial coma, or a diffuse brain lesion confirmed by imaging,Others includes skin, central nervous system, and unknown. ICH, intracerebral hemorrhage; SAE, sepsis associated encephalopathy; SIRS, systemic inflammatory response syndrome; DIC, disseminated intravascular coagulation; SOFA, Sequential [sepsis- related] Organ Failure Assessment (scale ranges from 0 to 4, ≥ 2 indicates organ failure, and higher scores indicate more severe organ failure);

 

RESULTS

A total of 716 adult acute ICH patients were recruited from the general ICU of Shuyang People’s Hospital. Of them, 209 ICH patients who were death or moribundity within first 24 hours were excluded due to missing data in their medical records. Ultimately, 507 acute ICH patients were included in the present investigation.

Of 507 acute ICH patients, 48.9% (248/507) of acute ICH cases were screened to infection events (SIRS criteria ≥ 2). The time of starting antibiotic treatment considered infection: about 20% was within initial 3 hrs. 65 % of the patients was in 4 hours later on ICU. Only 15% did not use any antibiotics. The diseases underlying of ICH and other baseline characteristics see in The Supplement Table II.

The characteristics of sepsis after acute ICH is shown in Table 1. A total of 189 sepsis after ICH were diagnosed by the inclusion criteria, which was in 37.3% (189/507) of acute ICH in ICU. The median time from onset to infection was 1.3 hours. The most common acute organ failure for sepsis after ICH was acute brain failure (74.6%). The mortality at initial 48 hours was in 49.5% and at 30 days in 55.6%.

Table 2 shows the results for variable on risk of ICH patients with and without sepsis within initial 48 hours. The early risk of sepsis after ICH patients at initial 48 hours was in 21.9% (111/507). We found that sepsis patients were significantly more likely to present with a lower GCS score (6.3 ± 1.5 vs 7.0 ± 2.3,), higher SOFA score (6.8 ± 1.9 vs. 3.8 ± 2.1), higher SIRS criteria (3.1 ± 1.1 vs. 1.4 ± 1.4), and no using antibiotic within initial 3 hours (89.2% vs. 78.5%) than those without sepsis(all p<0.05). The blood pressure of patients were significantly lower in the sepsis group than in the non-sepsis group (170.4 ± 43.4 vs.182.3 ± 37.9 and 96.5 ± 26.5 vs.102.3 ± 22.8, respectively). However, only higher SOFA score (OR, 1.5; 95% CI, 0.304- 0.673), higher SIRS criteria (OR, 1.5; 95% CI,1.209- 1.938), and no using antibiotics treatment within initial 3 hours (OR, 0.3; 95% CI, 0.153- 0.506) were established by logistic regression as independent risk factors for ICH patients with sepsis within initial 48 hours (Table 3).

The variables influencing outcome in ICH patients with and without sepsis at 30 days shows in the Table 4. Cox regression risk analysis demonstrated that only elevated lactate level (OR, 1.3; 95% CI,1.190-1.402; p=0.000) lower GCS score (OR, 0.7; 95% CI, 0.641-0.834; p=0.000) increased NIHSS score (OR, 1.1; 95% CI, 1.074-1.141; p=0.000)higher SOFA score (OR, 1.1; 95% CI, 1.032-1.151; p=0.009), and less ICU days (OR, 0.8; 95% CI, 0.734- 845; p=0.000) were significantly related to survival in acute ICH patient (Table 5).

Based on Kaplan- Meier survival curves that included ICH patients with and without sepsis events during the 30-day follow-up period, the ORs for worse survival was significantly associated with ICH patients with sepsis events (OR, 4.345; p=0.037) (Figure 1).

Table 2: Variables the risk of in ICH patients with and without sepsis within first 48 hours (n=507).

Variable ICH with sepsis at 48 hrs (n=111) ICH without sepsis at 48 hrs (n=396) p Value
Male gender (%) 69 (62.2) 231 (58.3) 0.513
Age (years, mean ± SD) 61.7 ± 13.0 63.2 ± 12.8 0.266
SBP (mmHg, mean ± SD) 170.4 ± 43.4 182.3 ± 37.9 0.015
DBP (mmHg, mean ± SD) 96.5 ± 26.5 102.3 ± 22.8 0.021
GCS score (mean ± SD) 6.3 ± 1.5 7.0 ± 2.3 0.002
INHSS score (mean ± SD) 27.5 ± 7.0 27.1 ± 6.9 0.614
Hematoma volume (mL, mean ± SD) 35.4 ± 28.9 38.7 ± 29.1 0.289
Lactic acid (mmol/L, mean ± SD) 2.4 ± 1.1 2.2 ± 1.2 0.143
Serum glucose (mean ± SD) 8.3 ± 3.0 8.2 ± 6.0 0.913
Sepsis-SOFA score (mean ± SD) 6.8 ± 1.9 3.8 ± 2.1 0
SIRS criteria,( mean ± SD) 3.1 ± 1.1 1.4 ± 1.4 0
No using antibiotic within initial 3 h, n (%) 99 (89.2) 311 (78.5) 0.013
Intubation breathing/mechanical ventilation, n (%) 82 (73.9) 276 (69.7) 0.412
Mortality at initial 2 days,n (%) 55 (49.5) 10 (2.5) 0
Abbreviations: ICH: intracerebral hemorrhage; SBP: systolic blood pressure; DBP: diastolic blood pressure; SIRS: systemic inflammatory response syndrome; GCS: Glasgow Coma Scale; SOFA: Sequential [sepsis-related] Organ Function Assessment.

Table 3: Logistic regression analysis to identify the early risk of ICH patients with sepsis within first 48 hours (n=507).

Variable OR 95% CI for OR p value
No using antibiotics within initial 3hrs 0.3 0.153-0.506 0
SIRS criteria≥2 1.5 1.209-1.938 0
SOFA score 1.5 1.304-1.718 0
Abbreviations: ICH: intracerebral hemorrhage; SIRS: systemic inflammatory response syndrome; SOFA: Sequential [sepsis-related] Organ Failure Assessment.

Table 4: Variables influencing outcome in ICH patients with and without sepsis at 30 days (n=507).

Variable ICH with sepsis At 30 d (n=189) ICH without sepsis at 30 d (n=318) p Value
Male gender (%) 114 (60.3) 186 (58.5) 0.709
Age (years, mean ± SD) 62.2 ± 12.5 63.3 ± 13.1 0.365
SBP (mmHg, mean ± SD) 172.7 ± 46.5 183.6 ± 34.3 0.003
DBP (mmHg, mean ± SD) 97.5 ± 27.9 103.1 ± 20.9 0.011
GCS score (mean ± SD) 6.3 ± 1.5 7.2 ± 2.4 0
Lactic acid (mmol/L, mean ± SD) 2.4 ± 1.1 2.1 ± 1.2 0
Serum glucose (mean ± SD) 8.7 ± 8.2 8.0 ± 3.1 0.222
Sepsis-SOFA score (mean ± SD) 7.2 ± 1.7 2.9 ± 1.0 0
SIRS criteria,( mean ± SD) 3.3 ± 0.8 0.9 ± 1.0 0
INHSS score (mean ± SD) 28.2 ± 6.6 26.6 ± 7.0 0.012
Nosocomial-onset coma, n (%) 43 (22.8) 24 (7.5) 0
Hematoma volume (mL, mean ± SD) 35.5 ± 28.2 39.4 ± 29.5 0.147
Intraventricular extension (%) 98 (51.9) 161(51.2) 0.854
Intubation breathing/echanical ventilation, n (%) 137 (72.5) 221 (69.5) 0.483
Operation, n (%) 53 (28.0) 74 (23.3) 0.245
GOS score at 30 days (%)  
4-5 score (%) 13 (6.9) 96 (30.2) 0
2-3 score (%) 71 (37.6) 92 (28.9) 0.049
1 score (%) 105 (55.6) 130 (40.9) 0.002
Abbreviations: ICH: intracerebral hemorrhage; SBP: systolic blood pressure; DBP: diastolic blood pressure; SIRS: systemic inflammatory response syndrome; GCS: Glasgow Coma Scale; SOFA: Sequential [sepsis-related] Organ Failure Assessment; GOS: Glasgow Outcome Scale (range from 1=death to 5=good recovery).

Table 5: Cox regression analysis to identify the influence on outcome in ICH patients with sepsis at 30 days (n=507).

Variable OR 95% CI for OR p value
Serum lactate level 1.3 1.190-1.402 0
GCS score 0.7 0.641-0.834 0
NIHSS score 1.1 1.074-1.141 0
SOFA score 1.1 1.032-1.151 0.002
ICU days 0.8 0.734-0.845 0
Abbreviations: ICH: intracerebral hemorrhage; GCS: Glasgow Coma Scale; NIHSS: National institutes of Health stroke scale; SOFA: Sequential [sepsisrelated] Organ Failure Assessment; ICU: intensive care unit.

 

DISCUSSION

Although the prevalence of sepsis (1.7%-33.7%) among acute ICH patients have been estimated by previous studies [17,18], the accurate risk for sepsis is still unclear. In the present study, 37.3% of sepsis events in acute ICH patients in ICU were diagnosed by jointing SIRS and SOFA criteria. Moreover, our data shown that the mortality of sepsis in patients with acute ICH at initial 48 hours was in 49.5% and at initial 30 days in 55.6%

In fact, several studies have demonstrated that the prevalence of infection among ICH patients is high [7,19-21], and that subsequent sepsis events in stroke patients are very common [22,23]. In the present study, we used the SIRS criteria to screen the early infection event, which was clearly shown that the prevalence of early infection among ICH patients was up to 48.9%.

Importantly, we found that the high risk sepsis after acute ICH mainly was within initial 48 hours on admission, not only indicated the early source of sepsis involved community acquired infection, but also suggested a time bundle for sepsis care and rapid treatment of antibiotics. And we also found that the most common acute organ failure for sepsis after ICH was acute brain failure. This is consistent with previous study [24].

Interestingly, we found that hematoma volumes did not differ between the groups within initial 48 hours, but an increase in the risk of death was observed in ICH patients with sepsis compared to those without sepsis. Therefore, our study indicated that sepsis after ICH contributed to an increased risk of death in patients with acute ICH.

More importantly, ICH patients with sepsis without using antibiotics treatment within initial 3 hours shown that a delay time given antibiotic treatment was associated with an high risk in-ICU mortality, which was confirmed by our study, supporting that rapid antibiotics treatment within the first 3 hours of sepsis can reduce hospital mortality [25].

Moreover, Cox regression analysis revealed that the risk factors for worse survival in sepsis after ICH at initial 30 days were related to the decreased GCS scores, less ICU days, higher NIHSS scores, higher SOFA scores, and elevated lactate level.

To the best of our knowledge, previous studies have found that a decreased GCS scores, increased ICH volume, and increased NIHSS scores was related to neurological deterioration and the high rate of poor outcomes in acute ICH patients [9,26,27], and our current study also found that the decreased GCS scores, increased ICH volume, and increased NIHSS scores were related to the worse outcomes. Although several large clinical studies also confirmed that an increased SOFA scores and elevated lactate levels is the main markers for sepsis in non-ICH population [8,11,13,28], we found that an elevated SOFA scores and elevated serum lactate levels were more likely to have a strong association with the risk of death in ICH population with sepsis at initial 30 days.

However, our data shown that a life-threatening risk of over 4-fold on death in ICH patients with sepsis was confirmed by a Kaplan–Meier curve analysis. Therefore, we considered that the optimal time of rapid antibiotics treatment for sepsis after ICH who had a median time from onset to infection only 1.3 hours has to perform within initial 1 hour on admission.

Some limitations of our study must be considered. First, based on SOFA clinical criteria, sepsis with a GCS4 as criteria of diagnosing sepsis events. Thus, the risk of septic events among acute ICH patients in the current study might be underestimated. Second, acute ICH with SAE is always a challenging diagnosis. The patients with SAE usually associated with a vasogenic brain edema or subcortical white matter ischemic lesions on imaging [30,31], which is more likely to be less sensitive on CT than on MRI. Thus, brain MRI scans for acute ICH patients with septic brain lesions are very important. However, MRI was less performed in the present study. Therefore, further prospective brain MR studies are needed.

CONCLUSIONS

Sepsis is a early frequent complication of acute ICH, and it greatly increases the risk of death among ICH patients in ICUs. Our findings demonstrate that the high risk sepsis after acute ICH mainly is within initial 48 hours on admission. The findings facilitate earlier identification and more timely antibiotics treatment for ICH patients with sepsis.

REFERENCES

1. Zhou YT, Tong DM, Wang SD. Acute spontaneous intracerebral hemorrhage and traumatic brain injury are the most common causes of critical illness in the ICU and have high early mortality. BMC Neurol. 2018; 18: 127.

2. Fogelholm R, Avikainen S, Murros K. Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke. 1997; 28: 1396-1400.

3. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association /American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007; 116: e391-e413.

4. Sun W, Pan W, Kranz PG, Hailey CE, Williamson RA, Sun W, et al. Predictors of late neurological deterioration after spontaneous intracerebral hemorrhage. Neurocrit Care. 2013; 19: 299-305.

5. Mascia L, Sakr Y, Pasero D, Payen D, Reinhart K, Vincent JL, et al. Extracranial complications in patients with acute brain injury: a post-hoc analysis of the SOAP study. Intensive Care Med. 2008; 34: 720- 727.

6. Lord AS, Langefeld CD, Sekar P, Moomaw CJ, Badjatia N, Vashkevich A, et al. Infection after intracerebral hemorrhage: risk factors and association with outcomes in the ethnic/racial variations of intracerebral hemorrhage study. Stroke. 2014; 45: 3535-3342.

7. Sykora M, Diedler J, Poli S. Autionomic shift and increased susceplibitity to infections after acute intracerebral hemorrhage. Stroke. 2011; 42: 1218-1223.

8. Singer M, Duetschmen CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315: 801-810.

9. Hemphill JC, Greenberg SM, Anderson CS, Anderson CS, Becker K, Bendok BR, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2015; 46: 2332-2360.

10. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003; 29: 530-538.

11. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315: 762-774.

12. Donnelly JP, Safford MM, Shapiro NI, Baddley JW, Wang HE. Application of the Third International Consensus Definitions for Sepsis (Sepsis-3) Classification: a retrospective population-based cohort study. Lancet Infect Dis. 2017; 17: 661-670.

13. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Med. Intensive care medicine. 1996; 22: 707-710.

14. Kwak R, Kadoya S, Suzuki T. Factors affecting the prognosis in thalamic hemorrhage. Stroke. 1983; 14: 493-500.

15. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997; 28: 1-5.

16. Plum F, Posner JB. Supratentorial lesions causing coma. In: The Diagnosis of Stupor and Coma. Third Edition. Philadelphia, FA Davis. 1980; 87-151.

17. Lyden PD, Shuaib A, Lees KR, Davalos A, Davis SM, Diener HC, et al. CHANT Trial Investigators. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke. 2007; 38: 2262-2269.

18. Swarna R, Richard R, Ausim A. Sepsis in intracranial hemorrhagyshould we be bugged? Stroke. 2015; 46: AWP336.

19. Sykora M, Diedler J, Poli S. Autionomic shift and increased susceplibitity to infections after acute intracerebral hemorrhage. Stroke. 2011; 42: 1218-1223.

20. Murthy SB, Moradiya Y, Shah J, Merkler AE, Mangat HS, Iadacola C, et al. Nosocomial Infections and Outcomes after Intracerebral Hemorrhage: A Population-Based Study. Neurocrit Care. 2016; 25: 178-184.

21. Yilmaz GR1, Cevik MA, Erdinc FS, Ucler S, Tulek N. The Risk Factors for Infections Acquired by Cerebral Hemorrhage and Cerebral Infarct Patients in a Neurology Intensive Care Unit in Turkey. Jpn J Infect Dis. 2007; 60: 87-91.

22. Park DW, Chun BC, Kim JM, Sohn JW, Peck KR, Kim YS, et al. Epidemiological and Clinical Characteristics of Community- acquired Severe Sepsis and Septic Shock: A Prospective Observational Study in 12 University Hospitals in Korea. J Korean Med Sci. 2012; 27: 1308- 1314.

23. Berger B, Gumbinger C, Steiner T, Sykora M. Epidemiologic features, risk factors, and outcome of sepsis in stroke patients treated on a neurologic intensive care unit. J Crit Care. 2014; 29: 241-248.

24. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol. 1993; 33: 94-100.

25. Seymour CW, Gesten F, Prescott HC, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. N Engl J Med. 2017; 376: 2235 -2244.

26. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage: A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993; 24: 987-993.

27. Cho DY, Chen CC, Lee HC, Lee WY, Lin HL. Glasgow Coma Scale and hematoma volume as criteria for treatment of putaminal and thalamic intracerebral hemorrhage. Surg Neurol. 2008; 70: 628-633.

28. Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015; 372: 1629-1638.

29. Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic encephalopathy definitions, etiologies, and mortalities. JAMA. 1996; 275: 470-473.

30. Polito A, Eischwald F, Maho AL, Polito A, Azabou E, Annane D, et al. Pattern of brain injury in the acute setting of human septic stroke. Crit Care. 2013; 17: R204.

31. Gofton TE, Young GB, Sepsis-associated encephalopathy. Nat Rev Neurol. 2012; 8: 557-566.

Tong DM, Zhou YT, Wang SD, Wang GS, Wang YW, et al. (2020) Early Risk and Influence Factors on Death of Sepsis Following Acute Intracerebral Hemorrhage: A Retrospective Cohort Study. J Neurol Disord Stroke 7(1): 1152.

Received : 21 Dec 2019
Accepted : 10 Jan 2020
Published : 14 Jan 2020
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X